Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000385546 | SCV000329737 | pathogenic | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published in vitro functional studies demonstrate significantly reduced protein expression in patient cells (Long et al., 2020); This variant is associated with the following publications: (PMID: 25525159, 15146475, 16429395, 32581362, 23590310, 30578397, 24591673, 16717148, 32733669, 31727138) |
Molecular Genetics and NGS Laboratory, |
RCV003389326 | SCV004101412 | pathogenic | Pulmonary hypertension, primary, 1; Pulmonary venoocclusive disease 1 | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Rare Disease Genomics Group, |
RCV000488654 | SCV000576093 | pathogenic | Pulmonary hypertension, primary, 1 | no assertion criteria provided | literature only | ||
NIHR Bioresource Rare Diseases, |
RCV001003684 | SCV001162127 | pathogenic | Pulmonary arterial hypertension | no assertion criteria provided | research | ||
Wendy Chung Laboratory, |
RCV001823883 | SCV002073594 | not provided | Pulmonary arterial hypertension; Idiopathic and/or familial pulmonary arterial hypertension | no assertion provided | literature only |